Global Anaesthesia Drugs Market 2019-2029
The global anaesthesia drugs market is expected to reach $11.8bn in 2024 and is estimated to grow at a CAGR of 3.9% from 2019-2024. The local anaesthesia segment accounted for the largest share in the anaesthesia drugs market in 2018.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 241-page report you will receive 129 tables and 117 figures– all unavailable elsewhere.
The 241-page report provides clear detailed insight into the global anaesthesia drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
- Global Anaesthesia Drugs Market forecasts from 2019-2029
- Along with revenue prediction for the overall world market for anaesthesia drugs market, our investigation shows forecasts to 2029 for the market segmented by type:
- Local Anaesthesia Drugs
- General Anaesthesia Drugs
- This report also provides revenue forecast to 2029 for these local anaesthesia drugs:
- Benzocaine
- Bupivacaine
- Chloroprocaine
- Lidocaine
- Prilocaine
- Ropivacaine
- Others
- This report also provides revenue forecast to 2029 for these general anaesthesia drugs:
- Desflurane
- Dexmedetomidine
- Midazolam
- Propofol
- Remifentanil
- Sevoflurane
- Others
- This report shows forecasts to 2029 for the market segmented by route of administration:
- Inhalation Anaesthesia Drugs
- Intravenous Anaesthesia Drugs
- Topical Anaesthesia Drugs
- Our analyses show individual revenue forecasts to 2029 for these regional and national markets:
- North America: US and Canada
- Europe: Germany, UK, France, Italy, Spain, Rest of Europe
- Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
- RoW: Brazil, Mexico, Russia, South Africa
- This report discusses these selected leading companies:
- Baxter International, Inc.
- AbbVie
- PAION AG
- Pfizer
- Hameln Pharmaceuticals
- AstraZeneca
- Fresenius Kabi
- Maruishi Pharmaceuticals
- Pacira Pharmaceuticals, Inc
- This report discusses promising drug candidates which are under development for the anaesthesia drugs market.
- Our study discusses trends as well as factors that drive and challenge the anaesthesia drugs market.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.
- 1. Report Overview
- 1.1 Why You Should Read This Report
- 1.2 How This Report Delivers
- 1.3 Key Questions Answered by This Analytical Report Include:
- 1.4 Who is This Report For?
- 1.5 Methodology
- 1.5.1 Primary Research
- 1.5.2 Secondary Research
- 1.5.3 Market Evaluation & Forecasting Methodology
- 1.6 Frequently Asked Questions (FAQ)
- 1.7 Associated Visiongain Reports
- 1.8 About Visiongain
- 2. Introduction to Anaesthetic Drugs
- 2.1 What is an Anaesthesia?
- 2.1.1 Types of Anaesthetics
- 2.1.1.1 General Anaesthetics
- 2.1.1.2 Local Anaesthetics
- 2.1.1.3 Sedation
- 2.2 What are the Risk and Side Effects of Anaesthesia Drugs?
- 2.2.1 Localized side effects
- 2.2.2 General side effects
- 2.3 Epidemiology of Anaesthetic Drugs
- 2.4 Humanistic and Economic Burden
- 2.4.1 Mortality
- 2.4.2 Morbidity
- 2.4.3 Economic Impact
- 3. Introduction to the Global Anaesthesia Drugs Market
- 4. Global Anaesthesia Drugs Market Forecast 2019-2029
- 5. Global Anaesthesia Drugs Market Forecast by Type, 2019-2029
- 5.1 Global Local Anaesthesia Drugs Market 2019-2029
- 5.2 Global General Anaesthesia Drugs Market 2019-2029
- 6. Global Anaesthesia Drugs Market Forecast by Routes of Administration, 2019-2029
- 6.1 Global Inhalation Anaesthesia Drugs Market 2019-2029
- 6.2 Global Intravenous Anaesthesia Drugs Market 2019-2029
- 6.3 Global Topical Anaesthesia Drugs Market 2019-2029
- 7. Global Anaesthesia Drugs by Regional and National Markets, 2019-2029
- 7.1 Anaesthesia Drugs Market by Region, 2018
- 7.2 North America Anaesthesia Drugs Market
- 7.2.1 North America Anaesthesia Drugs Market Forecast 2019-2029
- 7.2.2 North America Anaesthesia Drugs Market Forecast by Country, 2019-2029
- 7.2.3 North America Anaesthesia Drugs Market Forecast by Type, 2019-2029
- 7.2.4 North America Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.2.5 U.S. Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.2.6 Canada Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.3 Europe Anaesthesia Drugs Market
- 7.3.1 Europe Anaesthesia Drugs Market Forecast 2019-2029
- 7.3.2 Europe Anaesthesia Drugs Market Forecast by Country, 2019-2029
- 7.3.3 Europe Anaesthesia Drugs Market Forecast by Type, 2019-2029
- 7.3.4 Europe Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.3.5 Germany Anaesthesia Drugs Market Forecast by Route of Administration 2019-2029
- 7.3.6 UK Anaesthesia Drugs Market Forecast by Route of Administration 2019-2029
- 7.3.7 France Anaesthesia Drugs Market by Route of Administration, 2019-2029
- 7.3.8 Italy Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.3.9 Spain Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.3.10 Rest of Europe Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.4 Asia-Pacific Anaesthesia Drugs Market
- 7.4.1 Asia-Pacific Anaesthesia Drugs Market Forecast 2019-2029
- 7.4.2 Asia-Pacific Anaesthesia Market Forecast by Country, 2019-2029
- 7.4.3 Asia-Pacific Anaesthesia Drugs Market Forecast by Type, 2019-2029
- 7.4.4 Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.4.5 Japan Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.4.6 China Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.4.7 India Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.4.8 Rest of Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.5 RoW Anaesthesia Drugs Market
- 7.5.1 RoW Anaesthesia Drugs Market Forecast 2019-2029
- 7.5.2 RoW Anaesthesia Drugs Market Forecast by Country, 2019-2029
- 7.5.3 RoW Anaesthesia Drugs Market Forecast by Type, 2019-2029
- 7.5.4 RoW Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.5.6 Brazil Anaesthesia Market by Route of Administration, 2019-2029
- 7.5.7 Mexico Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
- 7.5.8 Russia Anaesthesia Drugs Market Forecast by Route of Administration, 2017-2029
- 7.5.9 South Africa Anaesthesia Market Forecast by Route of Administration, 2017-2029
- 8. Leading Drugs in the Global Anaesthesia Drugs Market, 2018
- 8.1 Propofol (Diprivan)
- 8.2 Sevoflurane (Sojourn, Ultane)
- 8.3 Remifentanil
- 8.4 Midazolam
- 8.5 Lidocaine
- 8.6 Ropivacaine
- 9. Market Growth Drivers
- 9.1 Increasing incidence of surgeries
- 9.2 Increasing cosmetic surgeries
- 9.3 Designated ICD-10 Code
- 9.4 Demand for general anaesthesia drugs
- 9.5 Increased investment in R&D
- 9.6 Advancements in medical power supply products
- 9.7 Rise in Geriatric population
- 10. Market Challenges
- 10.1 Healthcare consolidation
- 10.2 Stringent Regulatory Guidelines
- 10.3 Paucity of large, prospective and collaborative outcome studies
- 11. Market Trends
- 11.1 Advances in modern technologies
- 11.2 Strategic alliances among key players in the market
- 11.3 Expansion of healthcare sector in developing countries due to growing investments by major players
- 11.4 Advancements in drug delivery methods
- 11.5 Paucity of new drugs to change the practice of operating room Anaesthesia
- 11.6 Expect improved safety statistics regarding anaesthesia mortality and morbidity
- 11.7 Rising trend of home healthcare
- 12. Pipeline Molecules
- 12.1 Promising Potential Pipeline Molecules
- 12.1.1 Phase IV Molecules
- 12.1.1.1 Exparel (Bupivacaine Liposome)
- 12.1.2 Phase III Molecules
- 12.1.2.1 Remimazolam (CNS 7056)
- 12.1.3 Phase I Molecules
- 12.1.3.1 Cyclopropyl-methoxycarbonyl metomidate (ABP-700)
- 12.1.3.2 Carboetomidate
- 12.1.3.3 JM-1232 (-) (MR04A3)
- 12.1.3.4 Propofol
- 12.1.3.5 PF0713
- 12.1.3.6 Fospropofol
- 12.1.3.7 AZD-3043 (TD4756)
- 13. Leading Companies in Global Anaesthetic Drugs Market, 2018
- 13.1 Baxter International Inc.
- 13.2 AbbVie Inc.
- 13.3 PAION AG
- 13.4 Pfizer Inc.
- 13.5 Hameln Pharmaceuticals Ltd.
- 13.6 AstraZeneca
- 13.7 Fresenius Kabi
- 13.8 Maruishi Pharmaceuticals
- 13.9 Pacira Pharmaceuticals Inc.
- 13.10 Hospira Inc. (Pfizer Inc.)
- 13.10.1. Hospira Inc.: Product Portfolio
- 13.10.2. Recent Developments
- 13.10.2.1 Sale of Hospira’s Medical Devices Business to Enhance Operating Efficiency
- 13.10.2.2 Pfizer Expands Manufacturing Capacity for Sterile Injectable
- 13.11 Sandoz International GmbH (Novartis A.G)
- 13.11.1. Sandoz (Novartis A.G): Product Portfolio
- 13.11.2. Sandoz (Novartis A.G): Recent Development
- 13.11.2.1 Launch of First Generic of Suprane, in the U.S. is likely to Foster Market Share
- 13.12 Piramal Critical Care Inc. (Piramal Group)
- 13.12.1. Piramal Critical Care Inc. (Piramal Group): Product Portfolio
- 13.12.2. Piramal Critical Care Inc.: Recent Development
- 13.12.2.1 Strategic Acquisition to Rapidly Expand Product Offerings
- 13.12.2.2 Launch of Desflurane in 2019
- 13.13 Mylan N.V.
- 13.13.1. Mylan N.V.: Product Portfolio
- 13.13.2. Mylan N.V.: Recent Development
- 13.13.2.1 Acquisition China Player to Expand Geographical Reach
- 13.14 Aurobindo Pharma
- 13.14.1. Aurobindo Pharma: Product Portfolio
- 13.14.2. Aurobindo Pharma: Recent Developments
- 13.14.2.1 ANDA Approval
- 14. Conclusions
- Visiongain Report Sales Order Form
- Associated Visiongain Reports
- About Visiongain
- Visiongain report evaluation form
- List of Tables
- Table 2.1 Type of Surgeries performed in 2010 and 2020 (%)
- Table 4.1 Global Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 4.2 Global Anaesthesia Drugs Market by Regional Market Forecast 2019-2029 ($bn, AGR %, Cumulative)
- Table 4.3 Global Anaesthesia Drugs Market Forecast by Country 2019-2029 ($bn, AGR %, Cumulative)
- Table 5.1 Global Local Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 5.2 Global Local Anaesthesia Drugs Market by Drug, 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 5.3 Global General Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 5.4 Global General Anaesthesia Drugs Market by Drug, 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 6.1 Global Inhalation Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 6.2 Global Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 6.3 Global Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.1 North America Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.2 U.S. Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.3 Canada Anaesthesia Market Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.4 North America Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.5 North America Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.6 North America General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.7 North America General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.8 North America Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.9 North America Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.10 North America Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.11 U.S. Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.12 U.S. Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.13 U.S. Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.14 Canada Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.15 Canada Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.16 Canada Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.17 Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.18 Germany Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.19 UK Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.20 France Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.21 Italy Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.22 Spain Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.23 Rest of Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.24 Europe General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.25 Europe General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.26 Europe Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.27 Europe Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.28 Europe Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.29 Europe Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.30 Europe Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.31 Germany Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.32 Germany Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.33 Germany Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.34 UK Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.35 UK Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.36 UK Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.37 France Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.38 France Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.39 France Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.40 Italy Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.41 Italy Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.42 Italy Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.43 Spain Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.44 Spain Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.45 Spain Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.46 Rest of Europe Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.47 Rest of Europe Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.48 Rest of Europe Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.49 Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.50 Japan Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.51 China Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.52 India Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.53 Rest of Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.54 Asia-Pacific General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.55 Asia Pacific General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.56 Asia-Pacific Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.57 Asia Pacific Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.58 Asia-Pacific Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.59 Asia-Pacific Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.60 Asia-Pacific Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.61 Japan Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.62 Japan Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.63 Japan Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.64 China Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.65 China Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.66 China Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.67 India Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.68 India Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.69 India Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.70 Rest of Asia-Pacific Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.71 Rest of Asia-Pacific Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.72 Rest of Asia-Pacific Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.73 RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.74 Brazil Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.75 Mexico Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.76 Russia Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.77 South Africa Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.78 Rest of RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.79 RoW Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.80 RoW Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.81 RoW General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.82 RoW General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.83 RoW Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.84 RoW Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.85 RoW Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.86 Brazil Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.87 Brazil Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.88 Brazil Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.89 Mexico Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.90 Mexico Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.92 Mexico Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.92 Russia Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.93 Russia Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.94 Russia Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.95 South Africa Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.96 South Africa Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 7.97 South Africa Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
- Table 12.1 Active Pipeline Molecules under Development for Anaesthesia Drugs
- Table 13.1 Baxter: Overview
- Table 13.2 Baxter: Revenue ($m), Revenue Share (%) and AGR (%) Breakdown by Geographical Segment, 2016-2017
- Table 13.3 AbbVie: Overview
- Table 13.4 PAION AG: Overview
- Table 13.5 Pfizer: Overview
- Table 13.6 Hameln: Overview
- Table 13.7 AstraZeneca: Overview
- Table 13.8 Fresenius Kabi: Overview 2016
- Table 13.9 Maruishi: Overview
- Table 13.10 Pacira: Overview
- Table 13.11 Hospira Inc.: Overview, 2017
- Table 13.12 Hospira Inc.: Anaesthesia Drug Offerings
- Table 13.13. Sandoz: Overview, 2017
- Table 13.14. Sandoz.: Anaesthesia Drug Offerings
- Table 13.15: Piramal Critical Care Inc.: Overview, 2017
- Table 13.16. Piramal Critical Care Inc.: Anaesthesia Drug Offerings
- Table 13.17: Mylan N.V.: Overview, 2017
- Table 13.18: Mylan N.V..: Anaesthesia Drug Offerings
- Table 13.19: Aurobindo Pharma: Overview, 2017
- Table 13.20: Aurobindo Pharma: Anaesthesia Drug Offerings
- List of Figures
- Figure 4.1 Global Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
- Figure 4.2 Global Anaesthesia Market by Region (%), 2017-2029
- Figure 4.3 Global Anaesthesia Market by Type (%), 2017-2029
- Figure 4.4 Global Anaesthesia Market by Route of Administration (%), 2017-2029
- Figure 5.1 Global Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
- Figure 5.2 Global Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn)
- Figure 5.3 Global Local Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 5.4 Global Local Anaesthesia Drugs Market by Drug in 2024 (%)
- Figure 5.5 Global Local Anaesthesia Drugs Market by Drug in 2029 (%)
- Figure 5.6 Global General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
- Figure 5.7 Global General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
- Figure 5.8 Global General Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 5.9 Global General Anaesthesia Drugs Market by Drug in 2024 (%)
- Figure 5.10 Global General Anaesthesia Drugs Market by Drug in 2029 (%)
- Figure 6.1 Global Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
- Figure 6.2 Global Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
- Figure 7.1 Anaesthesia Drugs Market by Region (% Share), 2018
- Figure 7.2 Number of Inpatient Surgeries by Type in Canada, 2015-2016
- Figure 7.3 North America Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
- Figure 7.4 North America Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
- Figure 7.5 North America Anaesthesia Drugs Market by Country: (% Share), 2018
- Figure 7.6 North America Anaesthesia Drugs Market by Country: (% Share), 2024
- Figure 7.7 North America Anaesthesia Drugs Market by Country: (% Share), 2029
- Figure 7.8 North America Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
- Figure 7.9 North America Local Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 7.10 North America Local Anaesthesia Drugs Market by Drug in 2024 (%)
- Figure 7.11 North America Local Anaesthesia Drugs Market by Drug in 2029 (%)
- Figure 7.12 North America General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
- Figure 7.13 North America General Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 7.14 North America General Anaesthesia Drugs Market by Drug in 2024 (%)
- Figure 7.15 North America General Anaesthesia Drugs Market by Drug in 2029 (%)
- Figure 7.16 North America Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
- Figure 7.17 North America Anaesthesia Drugs Market by Type: (% Share), 2018
- Figure 7.18 North America Anaesthesia Drugs Market by Type: (% Share), 2024
- Figure 7.19 North America Anaesthesia Drugs Market by Type: (% Share), 2029
- Figure 7.20 North America Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
- Figure 7.21 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
- Figure 7.22 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
- Figure 7.23 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2029
- Figure 7.24 Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
- Figure 7.25 Europe Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
- Figure 7.26 Europe Anaesthesia Drugs Market by Country: (% Share), 2018
- Figure 7.27 Europe Anaesthesia Drugs Market by Country: (% Share), 2024
- Figure 7.28 Europe Anaesthesia Drugs Market by Country: (% Share), 2029
- Figure 7.29 Europe General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
- Figure 7.30 Europe General Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 7.31 Europe General Anaesthesia Drugs Market by Drug in 2024 (%)
- Figure 7.32 Europe General Anaesthesia Drugs Market by Drug in 2029 (%)
- Figure 7.33 Europe Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
- Figure 7.34 Europe Local Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 7.35 Europe Local Anaesthesia Drugs Market by Drug in 2024 (%)
- Figure 7.36 Europe Local Anaesthesia Drugs Market by Drug in 2029 (%)
- Figure 7.37 Europe Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
- Figure 7.38 Europe Anaesthesia Drugs Market by Type: (% Share), 2018
- Figure 7.39 Europe Anaesthesia Drugs Market by Type: (% Share), 2024
- Figure 7.40 Europe Anaesthesia Drugs Market by Type: (% Share), 2029
- Figure 7.41 Europe Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
- Figure 7.42 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
- Figure 7.43 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
- Figure 7.44 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2029
- Figure 7.45 Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
- Figure 7.46 Asia-Pacific Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
- Figure 7.47 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2018
- Figure 7.48 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2024
- Figure 7.49 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2029
- Figure 7.50 Asia Pacific General Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 7.51 Asia Pacific General Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 7.52 Asia Pacific General Anaesthesia Drugs Market by Drug in 2024 (%)
- Figure 7.53 Asia Pacific General Anaesthesia Drugs Market by Drug in 2029 (%)
- Figure 7.54 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
- Figure 7.55 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 7.56 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2024 (%)
- Figure 7.57 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2029 (%)
- Figure 7.58 Asia-Pacific Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
- Figure 7.59 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2018
- Figure 7.60 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2024
- Figure 7.61 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2029
- Figure 7.62 Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
- Figure 7.63 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
- Figure 7.64 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
- Figure 7.65 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2029
- Figure 7.66 RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
- Figure 7.67 RoW Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
- Figure 7.68 RoW Anaesthesia Drugs Market by Country: (% Share), 2018
- Figure 7.69 RoW Anaesthesia Drugs Market by Country: (% Share), 2024
- Figure 7.70 RoW Anaesthesia Drugs Market by Country: (% Share), 2029
- Figure 7.71 RoW Local Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 7.72 RoW Local Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 7.73 RoW Local Anaesthesia Drugs Market by Drug in 2024 (%)
- Figure 7.74 RoW Local Anaesthesia Drugs Market by Drug in 2029 (%)
- Figure 7.75 RoW General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
- Figure 7.76 RoW General Anaesthesia Drugs Market by Drug in 2018 (%)
- Figure 7.77 RoW General Anaesthesia Drugs Market by Drug in 2024 (%)
- Figure 7.78 RoW General Anaesthesia Drugs Market by Drug in 2029 (%)
- Figure 7.79 RoW Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
- Figure 7.80 RoW Anaesthesia Drugs Market by Type: (% Share), 2018
- Figure 7.81 RoW Anaesthesia Drugs Market by Type: (% Share), 2024
- Figure 7.82 RoW Anaesthesia Drugs Market by Type: (% Share), 2029
- Figure 7.83 RoW Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
- Figure 7.84 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
- Figure 7.85 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
- Figure 7.86 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 202
- Figure 13.1 Baxter: Revenue Share (%) Breakdown by Geographical Segment, 2017
- Figure 13.2 Baxter: SWOT Analysis
- Figure 13.3 AbbVie Inc.: Revenue Share (%) Breakdown by Product Segment, 2017
- Figure 13.4 AbbVie Inc.: Revenue Share (%) Breakdown by Geographic Area, 2017
- Figure 13.5 AbbVie Inc.: Sevoflurane Drug Revenue Share (%) Breakdown, 2017
- Figure 13.6 AbbVie: SWOT Analysis
- Figure 13.7 PAION AG: SWOT Analysis
- Figure 13.8 AstraZeneca: SWOT Analysis
- Figure 13.9 Fresenius Kabi: Revenue Share (%) Breakdown by Geographic Area, 2016-2017
- Figure 13.10 Fresenius Kabi: Revenue Share (%) Breakdown by Product Segment, 2016-2017
- Figure 13.11 Fresenius Kabi: SWOT Analysis
- Figure 13.12 Maruishi Pharmaceuticals: SWOT Analysis
- Figure 13.13 Pacira Pharmaceuticals: SWOT Analysis
- Figure 14.1 Anaesthesia Market by Type (% share 2019 & 2029)
- Figure 14.2 Anaesthesia Market by Route of Administration (% share 2019 & 2029)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook